These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35194061)

  • 21. INTRAVITREAL INJECTIONS OF ZIV-AFLIBERCEPT FOR DIABETIC MACULAR EDEMA: A Pilot Study.
    Andrade GC; Dias JR; Maia A; Farah ME; Meyer CH; Rodrigues EB
    Retina; 2016 Sep; 36(9):1640-5. PubMed ID: 26991646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of diazepam injection repackaged in glass unit-dose syringes.
    Smith FM; Nuessle NO
    Am J Hosp Pharm; 1982 Oct; 39(10):1687-90. PubMed ID: 7148844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. INTRAVITREAL ZIV-AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results.
    de Oliveira Dias JR; Costa de Andrade G; Kniggendorf VF; Novais EA; Takahashi VKL; Maia A; Meyer C; Watanabe SES; Farah ME; Rodrigues EB
    Retina; 2019 Apr; 39(4):648-655. PubMed ID: 29232334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH of anti-VEGF agents in the human vitreous: low impact of very different formulations.
    Sobolewska B; Heiduschka P; Bartz-Schmidt KU; Ziemssen F
    Int J Retina Vitreous; 2017; 3():22. PubMed ID: 28652928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical investigations of intravitreal ziv-aflibercept.
    de Oliveira Dias JR; Badaró E; Novais EA; Colicchio D; Chiarantin GM; Matioli MM; Verna C; Penha FM; Barros NM; Meyer CH; Farah ME; Rodrigues EB
    Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):577-84. PubMed ID: 25423640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteonecrosis of the jaw associated with ziv-aflibercept.
    Mawardi H; Enzinger P; McCleary N; Manon R; Villa A; Treister N; Woo SB
    J Gastrointest Oncol; 2016 Dec; 7(6):E81-E87. PubMed ID: 28078129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal injection of ziv-aflibercept in the treatment of choroidal and retinal vascular diseases.
    HodjatJalali K; Mehravaran S; Faghihi H; Hashemi H; Kazemi P; Rastad H
    J Curr Ophthalmol; 2017 Sep; 29(3):228-231. PubMed ID: 28913517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of terbutaline sulfate repackaged in disposable plastic syringes.
    Glascock JC; DiPiro JT; Cadwallader DE; Perri M
    Am J Hosp Pharm; 1987 Oct; 44(10):2291-3. PubMed ID: 3687970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ziv-aflibercept: a novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer.
    Chung C; Pherwani N
    Am J Health Syst Pharm; 2013 Nov; 70(21):1887-96. PubMed ID: 24128964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two Doses of Intravitreal Ziv-Aflibercept versus Bevacizumab in Treatment of Diabetic Macular Edema: A Three-Armed, Double-Blind Randomized Trial.
    Baghi A; Jabbarpoor Bonyadi MH; Ramezani A; Azarmina M; Moradian S; Dehghan MH; Nourinia R; Peyman GA; Yaseri M; Soheilian M
    Ophthalmol Retina; 2017; 1(2):103-110. PubMed ID: 31047266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety and efficacy of ziv-aflibercept in retinal diseases.
    Mansour AM; Ashraf M; Dedhia CJ; Charbaji A; Souka AAR; Chhablani J
    Br J Ophthalmol; 2017 Oct; 101(10):1374-1376. PubMed ID: 28270485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful single treatment with ziv-aflibercept for existing corneal neovascularization following ocular chemical insult in the rabbit model.
    Gore A; Horwitz V; Cohen M; Gutman H; Cohen L; Gez R; Kadar T; Dachir S
    Exp Eye Res; 2018 Jun; 171():183-191. PubMed ID: 29548928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SHORT-TERM SAFETY PROFILE OF INTRAVITREAL ZIV-AFLIBERCEPT.
    Chhablani J; Narayanan R; Mathai A; Yogi R; Stewart M
    Retina; 2016 Jun; 36(6):1126-31. PubMed ID: 26655620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
    Cleary JM; Horick NK; McCleary NJ; Abrams TA; Yurgelun MB; Azzoli CG; Rubinson DA; Brooks GA; Chan JA; Blaszkowsky LS; Clark JW; Goyal L; Meyerhardt JA; Ng K; Schrag D; Savarese DMF; Graham C; Fitzpatrick B; Gibb KA; Boucher Y; Duda DG; Jain RK; Fuchs CS; Enzinger PC
    Cancer; 2019 Jul; 125(13):2213-2221. PubMed ID: 30913304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab.
    Schargus M; Kopp KT; Helbig C; Frings A; Winter G
    Transl Vis Sci Technol; 2021 Aug; 10(9):21. PubMed ID: 34406342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes.
    Fischer JH; Cwik MJ; Luer MS; Sibley CB; Deyo KL
    Ann Pharmacother; 1997 May; 31(5):553-9. PubMed ID: 9161647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion.
    Paulose R; Chhablani J; Dedhia CJ; Stewart MW; Mansour AM
    Clin Ophthalmol; 2016; 10():1853-1858. PubMed ID: 27703326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Loading Doses of Ziv-Aflibercept and Aflibercept in Neovascular Age-Related Macular Degeneration.
    Ayachit A; Singh SR; Subramanyam A; Tiwari S; Heranjal A; Chattannavar G; Pandey P; Salti H; Mansour MA; Mansour A; Chhablani J
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):144-148. PubMed ID: 32175924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal Ziv-Aflibercept : Safety Analysis in Eyes Receiving More Than Ten Intravitreal Injections.
    Singh SR; Chattannavar G; Ayachit A; Pimentel MC; Alfaro A; Tiwari S; Heranjal A; Subramanyam A; Braimah IZ; Dhami A; Sachdev P; Mansour A; Chhablani J
    Semin Ophthalmol; 2020 Jan; 35(1):2-6. PubMed ID: 31690175
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravitreal Ziv-Aflibercept: A Comprehensive Review.
    Barmas-Alamdari D; D'Souza HS; Kapoor KG; Wagner AL
    Semin Ophthalmol; 2019; 34(6):420-435. PubMed ID: 31314638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.